[Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of pathologies accessible by transbronchial needle aspiration requiring anatomopathological diagnosis]

Pichon Riviere A, Augustovski F, Garcia Marti S, Glujovsky D, Alcaraz A, Lopez A, Bardach A, Ciapponi A, Rey-Ares L, Cesaroni S
Record ID 32014000302
Spanish
Authors' objectives: To assess the evidence available on the efficacy, safety and issues related with coverage policies on the use of endobronchial ultrasound in accessible pathologies by transbronchial needle aspiration requiring anatomopathological diagnosis.
Authors' recommendations: Based on the evidence found, EBUS could be considered a safe technique with sensitivity and diagnostic results similar to those of mediastinoscopy and higher than blind TBNA when it comes to identification of mediastinal and hilaradenopathy invasion in patients with suspected or diagnosed non-small cell lung cancer and higher than conventional needle aspiration, but lower than percutaneous transthoraxic needle aspiration in patients with peripheral lung nodules. The main obstacles found in the reviewed studies were in relation with the comparator description and variability among studies. Due to the high rate of false negatives, confirmation by more invasive techniques is recommended if results are negative or non conclusive.
Details
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Humans
  • Endoscopic Ultrasound-Guided Fine Needle Aspiration
  • Pathology, Clinical
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.